Filter News
Area of Research
- (-) Neutron Science (12)
- Advanced Manufacturing (3)
- Biology and Environment (12)
- Clean Energy (38)
- Computational Engineering (1)
- Computer Science (2)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (10)
- Fusion Energy (1)
- Isotope Development and Production (1)
- Isotopes (3)
- Materials (16)
- Materials for Computing (4)
- National Security (16)
- Nuclear Science and Technology (8)
- Quantum information Science (1)
- Sensors and Controls (1)
- Supercomputing (35)
News Topics
- (-) Artificial Intelligence (1)
- (-) Biomedical (4)
- (-) Cybersecurity (1)
- (-) Nuclear Energy (1)
- (-) Security (1)
- (-) Summit (4)
- (-) Transportation (2)
- 3-D Printing/Advanced Manufacturing (3)
- Big Data (1)
- Bioenergy (3)
- Biology (4)
- Biotechnology (1)
- Climate Change (1)
- Composites (1)
- Computer Science (6)
- Coronavirus (5)
- Decarbonization (1)
- Energy Storage (2)
- Environment (3)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (1)
- Materials (6)
- Materials Science (13)
- Microscopy (1)
- Nanotechnology (6)
- National Security (1)
- Neutron Science (40)
- Physics (7)
- Quantum Science (4)
- Space Exploration (1)
- Sustainable Energy (2)
Media Contacts
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.
Researchers used neutrons to probe a running engine at ORNL’s Spallation Neutron Source